Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk

Vascular Health and Risk Management

Volumn 9, Issue 1, 2013, Pages 729-737

  Lai, Hong ^a   Fishman, Elliot K ^a   Gerstenblith, Gary ^a   Moore, Richard ^a   Brinker, Jeffrey A ^a   Keruly, Jeanne C ^a   Chen, Shaoguang ^a   Detrick, Barbara ^a   Lai, Shenghan ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; Cocaine use; Prospective follow up study; Subclinical coronary artery disease; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; COCAINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AFRICAN AMERICAN; ARTICLE; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; CHOLESTEROL BLOOD LEVEL; COCAINE DEPENDENCE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VIRUS LOAD; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

AFRICAN AMERICANS; COCAINE USE; PROSPECTIVE FOLLOW-UP STUDY; SUBCLINICAL CORONARY ARTERY DISEASE; VITAMIN D DEFICIENCY;

AFRICAN AMERICANS; ASYMPTOMATIC DISEASES; BALTIMORE; COCAINE-RELATED DISORDERS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DRUG USERS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; VITAMIN D DEFICIENCY;

EID: 84889818477     PISSN: 11766344     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S50537     Document Type: Article

References (27)

1. Lai S, Lai H, Meng Q, et al. Effect of cocaine use on coronary calcification among black adults in Baltimore. Am J Cardiol. 2002;90:326-328.
2. Lai S, Lima JA, Lai H, et al. HIV-1 infection, cocaine, and coronary calcification. Arch Intern Med. 2005;165:690-695.
3. Lai S, Fishman EK, Lai H, et al. Long-term cocaine use and antiretroviral therapy are associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection. Clin Infect Dis. 2008;46:600-610.
4. Lai S, Bartlett J, Lai H, et al. Long-term combination antiretroviral therapy is associated with the risk of coronary plaques in African Americans with HIV infection. AIDS Patient Care STDS. 2009;23:815-824.
5. Lai H, Fishman EK, Gerstenblith G, et al. Vitamin D deficiency is associated with significant coronary stenoses in asymptomatic African American chronic cocaine users. Int J Cardiol. 2012;158:211-216.
6. Lai H, Gerstenblith G, Fishman EK, et al. Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection. Clin Infect Dis. 2012;54:1747-1755.
7. Lai H, Detrick B, Fishman EK, et al. Vitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary study. J Investig Med. 2012;60:801-807.
8. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002;76: 187-192.
9. Ferdinand KC. Coronary heart disease and lipid-modifying treatment in African American patients. Am Heart J. 2004;147:774-782.
10. Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837-1847.
11. Ersfeld DL, Rao DS, Body JJ, et al. Analytical and clinical validation of the 25(OH) vitamin D assay for the Liaison automated analyzer. Clin Biochem. 2004;37:867-874.
12. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503-511.
13. Miller JM, Rochitte CE, Dewey M, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008; 359:2324-2336.
14. Roger VL, Go AS, Lloyd-Jones DM, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation. 2011;123:e18-e209.
15. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
16. Anand DV, Lim E, Raval U, et al. Prevalence of silent myocardial ischemia in asymptomatic individuals with subclinical atherosclerosis detected by electron beam tomography. J Nucl Cardiol. 2004;11: 450-457.
17. Anderson JL, May HT, Horne BD, et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol. 2010;106:963-968.
18. American Heart Association. [homepage on the Internet]. What your cholesterol levels mean. [updated Sep 6, 2013] Available from: http://www.heart.org/HEARTORG/Conditions/Cholesterol/AboutCholesterol/What-Your-Cholesterol-Levels-Mean_UCM_305562_Article.jsp. Accessed September 8, 2013.
19. Pittas AG, Chung M, Trikalinos T, et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010;152:307-314.
20. Joergensen C, Reinhard H, Schmedes A, et al. Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate. Diabetes Care. 2012;35:168-172.
21. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690-693.
22. Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2007;167:1159-1165.
23. Krause R, Bühring M, Hopfenmüller W, et al. Ultraviolet B and blood pressure. Lancet. 1998;352:709-710.
24. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol. 2006;92:39-48.
25. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168: 1340-1349.
26. Yoon HC, Goldin JG, Greaser LE 3rd, et al. Interscan variation in coronary artery calcium quantification in a large asymptomatic patient population. AJR Am J Roentgenol. 2000;174:803-809.
27. Theodorou M, Sersté T, Van Gossum M, et al. Factors associated with vitamin D deficiency in a population of 2044 HIV-infected patients. Clin Nutr. April 25, 2013. [Epub ahead of print.]